Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The study aims to describe the biochemical coagulation profile and investigate the effect of
Low molecular weight heparin and Apixaban on this profile in patients with nephrotic
syndrome.